Titre :	Prospects for antisense nucleic acid therapy of cancer and AIDS
Type de document :	texte imprimé
Auteurs :	Eric Wickstrom, Éditeur scientifique
Editeur :	New York : John Wiley & Sons
Année de publication :	1991
Importance :	xiv, 269 p.
ISBN/ISSN/EAN :	978-0-471-56880-3
Langues :	Anglais (eng)
Tags :	CANCER DRUG THERAPY  ANTISENSE NUCLEIC ACIDS-Therapeutic use  CANCER-Genetic aspects  AIDS-Genetic aspects
Index. décimale :	EQ -Equipe-
Résumé :	"This study is designed to inform clinical investigators and biomedical researchers of the range of possible applications of a new technology which involves a direct genetic approach to the treatment of disease using nucleic acid therapeutics. These new DNA and RNA agents are intended to stop the growth of cancerous cells or to halt the production of HIV infected cells. The book details the rapid progress of this new technology from its theoretical stage to its current position at the verge of experimental clinical applications with provocative discussions of the therapeutic implications of the basic research."
Cote :	LCC/K
Num_Inv :	549

Prospects for antisense nucleic acid therapy of cancer and AIDS [texte imprimé] / Eric Wickstrom, Éditeur scientifique . - New York : John Wiley & Sons, 1991 . - xiv, 269 p.
ISBN : 978-0-471-56880-3
Langues : Anglais (eng)

Tags :	CANCER DRUG THERAPY  ANTISENSE NUCLEIC ACIDS-Therapeutic use  CANCER-Genetic aspects  AIDS-Genetic aspects
Index. décimale :	EQ -Equipe-
Résumé :	"This study is designed to inform clinical investigators and biomedical researchers of the range of possible applications of a new technology which involves a direct genetic approach to the treatment of disease using nucleic acid therapeutics. These new DNA and RNA agents are intended to stop the growth of cancerous cells or to halt the production of HIV infected cells. The book details the rapid progress of this new technology from its theoretical stage to its current position at the verge of experimental clinical applications with provocative discussions of the therapeutic implications of the basic research."
Cote :	LCC/K
Num_Inv :	549